These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7517470)

  • 21. [Report of the symposium on the use of the preparation vasoprostan in the treatment of arterial occlusive diseases of the extremities (meeting report)].
    Koshkin VM
    Grud Serdechnososudistaia Khir; 1991 Jul; (7):62-3. PubMed ID: 1777271
    [No Abstract]   [Full Text] [Related]  

  • 22. Pricing and reimbursement of pharmaceuticals: an evaluation of cost-containment strategies. Proceedings of a symposium. Talloires, France, July 21-22, 1993.
    Pharmacoeconomics; 1994; 6 Suppl 1():1-87. PubMed ID: 10184441
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostaglandin E1 in vascular disease. Symposium of the International Union of Angiology, 15th World Congress. Rome, 19th September 1989. Proceedings.
    Vasa Suppl; 1989; 28():5-60. PubMed ID: 2609243
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endovascular therapeutic techniques].
    Bilbao JI; Martínez de la Cuesta A; Domínguez Echavarri P; Cosín O; Desloques L; Zudaire B
    An Sist Sanit Navar; 2005; 28 Suppl 3():117-34. PubMed ID: 16511586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
    J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of ethaverine hydrochloride in patients with peripheral vascular disease.
    Asby GR; Stein M; Conrad MC; Michie DD
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1096-100. PubMed ID: 4215620
    [No Abstract]   [Full Text] [Related]  

  • 27. [A.V. Vishnevskiĭ's school and modern angiology].
    Krakovskiĭ NI; Zolotorevskiĭ VIa
    Khirurgiia (Mosk); 1974 Sep; (9):10-6. PubMed ID: 4617796
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings of the XII World Congress of the International Union of Phlebology--parallel session entitled medical and socioeconomic impact of venolymphatic disease: benefit of daflon 500 mg. London, 1995.
    Angiology; 1997 Jan; 48(1):21-98. PubMed ID: 9012311
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anticoagulant therapy of arterial occlusive diseases].
    Schimpf K
    Dtsch Med J; 1967 May; 18(10):313-7. PubMed ID: 5612095
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: Indications and results of fibrinolytic treatment with streptokinase in chronic arterial stenoses and occlusions; a multicentre trial of 708 patients.
    Schmutzler R
    Thromb Diath Haemorrh; 1975 Nov; 34(2):569. PubMed ID: 1105878
    [No Abstract]   [Full Text] [Related]  

  • 31. [Conservative therapy of arterial occlusive diseases on a rational basis].
    Alexander K
    Dtsch Med J; 1972 May; 23(5):343-8. PubMed ID: 5036945
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings of the Sixth International Workshop on Structure and Function of the Vascular System. February 1-3, 2007. Paris, France.
    Hypertension; 2007 Jul; 50(1):152-267. PubMed ID: 17582008
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fibrinolysis in internal medicine].
    Breda R; Bizzi B
    Minerva Med; 1972 Dec; 63(88):4803-7. PubMed ID: 4641450
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the effects of vasoactive drugs on cutaneous microcirculation by laser Doppler velocimetry.
    Leonardo G; Arpaia MR; Del Guercio R
    Angiology; 1986 Jan; 37(1):12-20. PubMed ID: 3511773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of antithrombotic drugs in the treatment of peripheral occlusive arterial diseases].
    Violi F
    Minerva Cardioangiol; 1999 Nov; 47(11):416. PubMed ID: 10681239
    [No Abstract]   [Full Text] [Related]  

  • 36. [Medicinal prevention and therapy of arterial occlusive diseases of the extremities].
    Hild R
    Dtsch Med J; 1967 May; 18(10):306-12. PubMed ID: 5612094
    [No Abstract]   [Full Text] [Related]  

  • 37. [First clinical experiences with Dusodril in arterial occlusive diseases].
    Berghaus H; Senge T
    Hippokrates; 1968 May; 39(9):349-51. PubMed ID: 5712078
    [No Abstract]   [Full Text] [Related]  

  • 38. [On prolonged hemokinetic therapy of occlusive arterial diseases].
    Alegría A
    Med Klin; 1965 Jul; 60(28):1126-31. PubMed ID: 5835983
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA; Goyle KB
    Br J Surg; 1976 Aug; 63(8):661-2. PubMed ID: 953495
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thrombophilias and peripheral arterial occlusive disease].
    Le Hello C; Blacher J; Conard J; Piette JC; Constans J
    J Mal Vasc; 2008 Sep; 33(3):126-36. PubMed ID: 18554834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.